Skip to main content
Equibles

FMR LLC

Position in IMVT — Immunovant, Inc.

CIK 315066 BOSTON, MA
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$623,664,648
+$202,679,112 QoQ
Shares Held
16,186,469
-4.5% QoQ
Ownership
7.84%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1
of 226 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. IMVT ranks #26 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in IMVT

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $623,664,648 16,186,469
2026-03-31 $420,985,536 16,947,888
2025-12-31 $431,904,965 16,990,754
2025-09-30 $237,440,424 14,729,555
2025-06-30 $297,587,120 18,599,195
2025-03-31 $294,649,285 17,241,035
2024-12-31 $324,435,351 13,097,915
2024-09-30 $357,446,147 12,537,571
2024-06-30 $276,774,509 10,483,883
2024-03-31 $247,363,582 7,655,945
2023-12-31 $331,808,379 7,875,822
2023-09-30 $297,466,679 7,748,546
2023-06-30 $99,665,875 5,253,868
2023-03-31 $64,319,488 4,146,969
2022-12-31 $44,164,360 2,488,133
2022-09-30 $4,034 723
2022-06-30 $2,729 700
2022-03-31 $4,920 893
2020-09-30 $7,038,000 200,000